# The cystic fibrosis pathogen Achromobacter xylosoxidans inhibits biofilm formation of Pseudomonas aeruginosa

**Authors:** Cecilia Sahl, Agnes Andersson, Natalie Larsson, Magnus Paulsson, Oonagh Shannon, Lisa I. Påhlman

PMC · DOI: 10.1099/jmm.0.002051 · Journal of Medical Microbiology · 2025-08-01

## TL;DR

Achromobacter xylosoxidans can prevent Pseudomonas aeruginosa from forming biofilms in cystic fibrosis, which may impact lung health.

## Contribution

This study reveals that A. xylosoxidans inhibits P. aeruginosa biofilm formation through direct live-cell interactions during early stages.

## Key findings

- Early-stage A. xylosoxidans isolates inhibit P. aeruginosa biofilm formation in a concentration-dependent manner.
- The inhibition is not due to nutrient depletion but requires live-cell interactions during the attachment phase.
- A. xylosoxidans adheres more strongly to surfaces than P. aeruginosa.

## Abstract

Background.
Achromobacter xylosoxidans and Pseudomonas aeruginosa are two pathogens that cause persistent airway infections in individuals with cystic fibrosis (CF). The persistence of P. aeruginosa is partly due to a high capacity to form biofilms and the ability to exert antagonism against other bacteria. Loss of microbial diversity in conjunction with chronic P. aeruginosa colonization is strongly correlated with low lung function in CF. A. xylosoxidans and P. aeruginosa are frequently co-isolated in CF airway cultures. This study aims to investigate the reciprocal effects on growth inhibition and biofilm formation between P. aeruginosa and A. xylosoxidans in vitro.

Method. Six isolates of A. xylosoxidans, isolated from three CF patients in early and late stages of a chronic infection, were cultured together with a CF isolate of P. aeruginosa. Biofilm formation was assessed using a microtiter assay and crystal violet staining. Quantitative PCR was used to quantify species proportions in biofilms. Growth curves were performed to compare planktonic growth rates.

Results. Three A. xylosoxidans isolates, all of which were from early-stage infections, inhibited biofilm formation of P. aeruginosa. The inhibition was concentration-dependent and required the interaction of live bacteria during the early stages of biofilm development. The inhibitory effect was not caused by nutrient depletion of the planktonic cells. The selected A. xylosoxidans isolate had a stronger capacity to adhere to plastic surfaces compared to the P. aeruginosa isolate.

Conclusions. A. xylosoxidans can inhibit P. aeruginosa biofilm formation in vitro. The observed effect requires active interactions between live cells during the attachment stage of biofilm formation, possibly due to differences in adhesion capacity.

## Linked entities

- **Diseases:** cystic fibrosis (MONDO:0009061)
- **Species:** Achromobacter xylosoxidans (taxon 85698), Pseudomonas aeruginosa (taxon 287)

## Full-text entities

- **Diseases:** CF (MESH:D003550), airway infections (MESH:D007239)
- **Chemicals:** crystal violet (MESH:D005840)
- **Species:** Pseudomonas aeruginosa (species) [taxon 287], Homo sapiens (human, species) [taxon 9606], Achromobacter xylosoxidans (species) [taxon 85698]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12316436/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12316436/full.md

## References

27 references — full list in the complete paper: https://tomesphere.com/paper/PMC12316436/full.md

---
Source: https://tomesphere.com/paper/PMC12316436